FOSAPREPITANT
- Product NDC
- 70625-311
- 11-digit product format
- 706250311
- Labeler code
- 70625
- Product ID
- 70625-311_cdb56efb-a4d1-bd86-e053-2a95a90aeb78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FOSAPREPITANT
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Praxgen Pharmaceuticals LLC
- Application
- ANDA213199
- Marketing category
- ANDA
- Marketing start
- 2021-11-03
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/mL
- Pharmacologic classes
- Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70625-311-01 | 70625031101 | 1 VIAL in 1 CARTON (70625-311-01) > 5 mL in 1 VIAL | 1 vial | 2021-11-03 | 0000-00-00 | No | No | Current |